The chart shows the currently available prescription but they can be a useful tool to help you make the necessary diet Arena Pharmaceuticals; http. Jul 18, · On Tuesday, the FDA approved Qsymia, the second new diet drug in a month, and the most effective of the weight-loss pills that the agency has considered in. Learn about using prescription pills for weight loss including effectiveness and the types of also called anti-obesity drugs or “diet pills”, In , the.
On Tuesday, the Food and Drug Administration FDA approved Qsymia, the second new diet drug in a month, and the most effective of the weight-loss pills that the agency has considered in recent years. Qsymia, made by Vivus Inc. Diet pills have had a spotty history with the FDA, largely because of safety problems involving the heart.
Other drugs — most notably fenfluramine, used in the popular weight-loss combination fen-phen — have been withdrawn from the market for such hazards, and new drugs have had to clear a high bar for consideration. Who can use Qsymia? The drug is approved for obese adults with a body mass index, or BMI, of 30 or higher.
It can also be used by overweight adults, with a BMI of 27 or higher, if they have at least one weight-related condition such as high blood pressure, Type 2 diabetes or high cholesterol. How does it work? Qsymia is a combination of two existing drugs: Some doctors have already been prescribing the two drugs together for weight loss. How much weight will I lose? In clinical trials, overweight and obese patients taking Qsymia for a year lost differing amounts of weight: Most of the weight came off in the first three months, so doctors should monitor patients at that point to see if the drug is working.
The drug is designed to be used in conjunction with traditional weight-management strategies like diet and exercise. The Secrets to Weight Loss: What if I just want to drop a few pounds? Doctors stress that because of the potential risks of the drug, dieters should not use the drug for cosmetic weight loss.
Of course, concerns remain that once the drug is on the market, doctors can prescribe it to all comers. What are the risks? Potential heart problems and birth defects. In trials, some people taking Qsymia had an increased heart rate as well as a condition called metabolic acidosis, which can lead to hyperventilation, fatigue and anorexia. One of the ingredients in Qsymia, topiramate, has also been linked in previous studies to birth defects including cleft lip and cleft palate in women who take it during pregnancy.
The company says no birth defects occurred. People with recent or unstable heart disease or stroke are not recommended to take the drug because of the potential heart risks. Vivus has also agreed to continue monitoring Qsymia users for side effects after the drug reaches market; in particular, it will conduct a long-term cardiovascular outcomes trial to assess the effect of Qsymia on major events like heart attack and stroke.
Which is better, Qsymia or Belviq? In clinical trials, people taking Qsymia lost more weight; those taking Belviq lost 5. Based on the side effects profiles, however, some might consider Belviq to be less risky. Why is this approval important?
Aside from diet and exercise or weight-loss surgery, patients have few options. How do you pronounce the name of this pill? Qsymia is pronounced cue-SIM-ee-uh.
Find her on Twitter at aliceparkny.